Boon Cher Goh
National University Hospital, Singapore · National University of Singapore · Study Principal Investigator
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
16
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
74
PubMed author-name match
Trials
Studies that name Boon Cher Goh as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:26 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05236608 · A Study to Evaluate the Combination of Nivolumab With ADG106 in Metastatic NSCLCNational University Hospital, Singapore · unknown · Metastatic Non Small Cell Lung Cancer · principal investigator
- Ph2NCT04946968 · Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging BiomarkersNational Cancer Centre, Singapore · active not recruiting · Advanced Solid Tumours, Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma · principal investigator
- Ph2NCT04627961 · A Trial of LONSURF in Recurrent/Metastatic Nasopharyngeal CarcinomaNational University Hospital, Singapore · unknown · Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma · principal investigator
- Ph2NCT04533321 · A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell CarcinomaNational University Hospital, Singapore · unknown · Squamous Cell Carcinoma · principal investigator
- N/ANCT03938012 · Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell CarcinomaNational University Hospital, Singapore · unknown · Squamous Cell Carcinoma of the Lung, Squamous Cell Carcinoma of the Head and Neck · principal investigator
- Ph1/Ph2NCT03813394 · Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPCNational University Hospital, Singapore · active not recruiting · Locally Recurrent Cancer, Metastatic Nasopharyngeal Cancer · principal investigator
- Ph1NCT03282617 · Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal CarcinomaNational University Hospital, Singapore · unknown · Nasopharyngeal Cancer · principal investigator
- Ph1NCT02078349 · Phase I Study of KPT330 in Asian PatientsNational University Hospital, Singapore · completed · Solid Tumors · principal investigator
- Ph2NCT01309633 · Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)National University Hospital, Singapore · completed · Nasopharyngeal Carcinoma · principal investigator
- Ph2/Ph3NCT01189903 · Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer PatientsNational University Hospital, Singapore · unknown · Asian Colorectal Cancer Patients · principal investigator
- Ph4NCT00808184 · Pharmacokinetic Study of CPT-11, Raltegravir and Midazolam With Characterisation of UGT1A1 GenotypeNational University Hospital, Singapore · completed · Solid Tumor · principal investigator
- Ph1NCT00741234 · A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With AzacitidineS*BIO · completed · Solid Tumors, Hematologic Malignancies, Myelodysplastic Syndrome · principal investigator
- Ph1/Ph2NCT00703378 · Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic CycleNational University Hospital, Singapore · completed · Solid Tumors · principal investigator
- Ph3NCT00700895 · Assessing the Clinical Benefits of a Pharmacogenetics-Guided Dosing Regiment for Calculating Warfarin Maintenance DoseNational University Hospital, Singapore · unknown · Indications for Warfarin Therapy · principal investigator
- Ph2NCT00697437 · Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of DocetaxelNational University Hospital, Singapore · completed · Solid Tumors · principal investigator
- Ph2NCT00212043 · Phase I/II Trial of Infusional Gemcitabine in Combination With Carboplatin in Chemonaive Non-small Cell CarcinomaNational University Hospital, Singapore · completed · Non Small Cell Lung Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:26 UTC. The ranking covers the 200 most relevant of 74 PubMed records, and a shared surname and initials can bring in a namesake. All 74 on PubMed
- Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).J Clin Oncol · 2018380 citationsRCR 13.7
- Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.Lancet Oncol · 2010326 citationsRCR 8.5
- Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma.J Clin Oncol · 2005221 citationsRCR 4.8
- 169 citationsRCR 4.1
- Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.Ann Oncol · 2019147 citationsRCR 4.7
- 142 citationsRCR 4.1
- A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.J Clin Endocrinol Metab · 2012136 citationsRCR 4.0
- 106 citationsRCR 2.6
- Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients.Ann Oncol · 200395 citationsRCR 1.9
- A Phase II study of pazopanib in Asian patients with recurrent/metastatic nasopharyngeal carcinoma.Clin Cancer Res · 201187 citationsRCR 2.3